| Year |
Citation |
Score |
| 2019 |
Knopp KL, Simmons RMA, Guo W, Adams BL, Gardinier KM, Gernert DL, Ornstein PL, Porter W, Reel J, Ding C, Wang H, Qian Y, Burris KD, Need A, Barth V, ... ... Nisenbaum ES, et al. Modulation of TARP γ8-containing AMPA Receptors as a Novel Therapeutic Approach for Chronic Pain. The Journal of Pharmacology and Experimental Therapeutics. PMID 30910921 DOI: 10.1124/Jpet.118.250126 |
0.341 |
|
| 2019 |
Wu B, McDermott J, Krajewski J, Knopp KL, Nisenbaum E, Cummins T, Tan Z. [EXPRESS] Extracellular signal-regulated kinases mediate the enhancing effects of inflammatory mediators on resurgent currents in dorsal root ganglion neurons. Molecular Pain. 1744806919837104. PMID 30803321 DOI: 10.1177/1744806919837104 |
0.317 |
|
| 2017 |
Copeland CS, Wall TM, Sims RE, Neale SA, Nisenbaum E, Parri HR, Salt TE. Astrocytes modulate thalamic sensory processing via mGlu2 receptor activation. Neuropharmacology. PMID 28416443 DOI: 10.1016/J.Neuropharm.2017.04.019 |
0.364 |
|
| 2014 |
Tan ZY, Piekarz AD, Priest BT, Knopp KL, Krajewski JL, McDermott JS, Nisenbaum ES, Cummins TR. Tetrodotoxin-resistant sodium channels in sensory neurons generate slow resurgent currents that are enhanced by inflammatory mediators. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 7190-7. PMID 24849353 DOI: 10.1523/Jneurosci.5011-13.2014 |
0.361 |
|
| 2011 |
Caraci F, Molinaro G, Battaglia G, Giuffrida ML, Riozzi B, Traficante A, Bruno V, Cannella M, Merlo S, Wang X, Heinz BA, Nisenbaum ES, Britton TC, Drago F, Sortino MA, et al. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective. Molecular Pharmacology. 79: 618-26. PMID 21159998 DOI: 10.1124/Mol.110.067488 |
0.353 |
|
| 2010 |
Kato AS, Gill MB, Ho MT, Yu H, Tu Y, Siuda ER, Wang H, Qian YW, Nisenbaum ES, Tomita S, Bredt DS. Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins. Neuron. 68: 1082-96. PMID 21172611 DOI: 10.1016/J.Neuron.2010.11.026 |
0.357 |
|
| 2008 |
Kato AS, Siuda ER, Nisenbaum ES, Bredt DS. AMPA receptor subunit-specific regulation by a distinct family of type II TARPs. Neuron. 59: 986-96. PMID 18817736 DOI: 10.1016/J.Neuron.2008.07.034 |
0.322 |
|
| 2007 |
Kato AS, Zhou W, Milstein AD, Knierman MD, Siuda ER, Dotzlaf JE, Yu H, Hale JE, Nisenbaum ES, Nicoll RA, Bredt DS. New transmembrane AMPA receptor regulatory protein isoform, gamma-7, differentially regulates AMPA receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 4969-77. PMID 17475805 DOI: 10.1523/Jneurosci.5561-06.2007 |
0.318 |
|
| 2007 |
Rorick-Kehn LM, Johnson BG, Burkey JL, Wright RA, Calligaro DO, Marek GJ, Nisenbaum ES, Catlow JT, Kingston AE, Giera DD, Herin MF, Monn JA, McKinzie DL, Schoepp DD. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039). The Journal of Pharmacology and Experimental Therapeutics. 321: 308-17. PMID 17204749 DOI: 10.1124/jpet.106.110809 |
0.322 |
|
| 2006 |
Alt A, Nisenbaum ES, Bleakman D, Witkin JM. A role for AMPA receptors in mood disorders. Biochemical Pharmacology. 71: 1273-88. PMID 16442080 DOI: 10.1016/J.Bcp.2005.12.022 |
0.315 |
|
| 2005 |
Johnson MP, Barda D, Britton TC, Emkey R, Hornback WJ, Jagdmann GE, McKinzie DL, Nisenbaum ES, Tizzano JP, Schoepp DD. Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s). Psychopharmacology. 179: 271-83. PMID 15717213 DOI: 10.1007/s00213-004-2099-9 |
0.334 |
|
| 2004 |
Johnson MP, Nisenbaum ES, Large TH, Emkey R, Baez M, Kingston AE. Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists. Biochemical Society Transactions. 32: 881-7. PMID 15494040 DOI: 10.1042/BST0320881 |
0.33 |
|
| 2003 |
Murray TK, Whalley K, Robinson CS, Ward MA, Hicks CA, Lodge D, Vandergriff JL, Baumbarger P, Siuda E, Gates M, Ogden AM, Skolnick P, Zimmerman DM, Nisenbaum ES, Bleakman D, et al. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics. 306: 752-62. PMID 12730350 DOI: 10.1124/Jpet.103.049445 |
0.319 |
|
| 2002 |
Zhai J, Tian MT, Wang Y, Yu JL, Köster A, Baez M, Nisenbaum ES. Modulation of lateral perforant path excitatory responses by metabotropic glutamate 8 (mGlu8) receptors. Neuropharmacology. 43: 223-30. PMID 12213276 DOI: 10.1016/S0028-3908(02)00087-4 |
0.409 |
|
| 2001 |
Baumbarger PJ, Muhlhauser M, Zhai J, Yang CR, Nisenbaum ES. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator. The Journal of Pharmacology and Experimental Therapeutics. 298: 86-102. PMID 11408529 |
0.434 |
|
| 2001 |
Baumbarger P, Muhlhauser M, Yang CR, Nisenbaum ES. LY392098, a novel AMPA receptor potentiator: electrophysiological studies in prefrontal cortical neurons. Neuropharmacology. 40: 992-1002. PMID 11406190 DOI: 10.1016/S0028-3908(00)00195-7 |
0.504 |
|
| 1999 |
Gabel LA, Nisenbaum ES. Muscarinic receptors differentially modulate the persistent potassium current in striatal spiny projection neurons. Journal of Neurophysiology. 81: 1418-23. PMID 10085367 DOI: 10.1152/Jn.1999.81.3.1418 |
0.452 |
|
| 1998 |
Nisenbaum ES, Mermelstein PG, Wilson CJ, Surmeier DJ. Selective blockade of a slowly inactivating potassium current in striatal neurons by (+/-) 6-chloro-APB hydrobromide (SKF82958). Synapse (New York, N.Y.). 29: 213-24. PMID 9635891 DOI: 10.1002/(SICI)1098-2396(199807)29:3<213::AID-SYN3>3.0.CO;2-9 |
0.434 |
|
| 1998 |
Gabel LA, Nisenbaum ES. Biophysical characterization and functional consequences of a slowly inactivating potassium current in neostriatal neurons. Journal of Neurophysiology. 79: 1989-2002. PMID 9535963 DOI: 10.1152/Jn.1998.79.4.1989 |
0.398 |
|
| 1995 |
Nisenbaum ES, Wilson CJ. Potassium currents responsible for inward and outward rectification in rat neostriatal spiny projection neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 4449-63. PMID 7790919 |
0.325 |
|
| 1995 |
Nisenbaum E, Wilson C. Potassium currents responsible for inward and outward rectification in rat neostriatal spiny projection neurons The Journal of Neuroscience. 15: 4449-4463. DOI: 10.1523/JNEUROSCI.15-06-04449.1995 |
0.317 |
|
| 1994 |
Nisenbaum ES, Xu ZC, Wilson CJ. Contribution of a slowly inactivating potassium current to the transition to firing of neostriatal spiny projection neurons. Journal of Neurophysiology. 71: 1174-89. PMID 8201411 |
0.325 |
|
| 1993 |
Bernath S, Zigmond MJ, Nisenbaum ES, Vizi ES, Berger TW. Na+ influx through Ca2+ channels can promote striatal GABA efflux in Ca(2+)-deficient conditions in response to electrical field depolarization. Brain Research. 632: 232-8. PMID 8149231 DOI: 10.1016/0006-8993(93)91158-O |
0.444 |
|
| 1993 |
Nisenbaum ES, Berger TW, Grace AA. Depression of glutamatergic and GABAergic synaptic responses in striatal spiny neurons by stimulation of presynaptic GABAB receptors. Synapse (New York, N.Y.). 14: 221-42. PMID 8105549 DOI: 10.1002/syn.890140306 |
0.644 |
|
| 1992 |
Nisenbaum ES, Grace AA, Berger TW. Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic inputs--II. In vitro analysis. Neuroscience. 48: 579-93. PMID 1351271 DOI: 10.1016/0306-4522(92)90403-O |
0.66 |
|
| 1992 |
Nisenbaum ES, Berger TW, Grace AA. Presynaptic modulation by GABAB receptors of glutamatergic excitation and GABAergic inhibition of neostriatal neurons. Journal of Neurophysiology. 67: 477-81. PMID 1349038 DOI: 10.1152/Jn.1992.67.2.477 |
0.628 |
|
| 1992 |
Nisenbaum ES, Berger TW. Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic inputs--I. In vivo analysis. Neuroscience. 48: 561-78. PMID 1318517 DOI: 10.1016/0306-4522(92)90402-N |
0.637 |
|
| 1988 |
Nisenbaum ES, Orr WB, Berger TW. Evidence for two functionally distinct subpopulations of neurons within the rat striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 8: 4138-50. PMID 3183715 DOI: 10.1523/Jneurosci.08-11-04138.1988 |
0.597 |
|
| 1988 |
Nisenbaum ES, Stricker EM, Zigmond MJ, Berger TW. Spontaneous activity of type II but not type I striatal neurons is correlated with recovery of behavioral function after dopamine-depleting brain lesions. Brain Research. 473: 389-93. PMID 3148358 DOI: 10.1016/0006-8993(88)90872-4 |
0.573 |
|
| 1986 |
Nisenbaum ES, Stricker EM, Zigmond MJ, Berger TW. Long-term effects of dopamine-depleting brain lesions on spontaneous activity of type II striatal neurons: relation to behavioral recovery. Brain Research. 398: 221-30. PMID 3099976 DOI: 10.1016/0006-8993(86)91481-2 |
0.519 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2010 |
Kato AS, Gill MB, Yu H, Nisenbaum ES, Bredt DS. TARPs differentially decorate AMPA receptors to specify neuropharmacology. Trends in Neurosciences. 33: 241-8. PMID 20219255 DOI: 10.1016/J.Tins.2010.02.004 |
0.3 |
|
| 2005 |
O'Neill MJ, Murray TK, Clay MP, Lindstrom T, Yang CR, Nisenbaum ES. LY503430: pharmacology, pharmacokinetics, and effects in rodent models of Parkinson's disease. Cns Drug Reviews. 11: 77-96. PMID 15867954 |
0.297 |
|
| 2004 |
O'Neill MJ, Bleakman D, Zimmerman DM, Nisenbaum ES. AMPA receptor potentiators for the treatment of CNS disorders. Current Drug Targets. Cns and Neurological Disorders. 3: 181-94. PMID 15180479 DOI: 10.2174/1568007043337508 |
0.295 |
|
| 2002 |
Quirk JC, Nisenbaum ES. LY404187: a novel positive allosteric modulator of AMPA receptors. Cns Drug Reviews. 8: 255-82. PMID 12353058 |
0.294 |
|
| 2021 |
Copeland CS, Neale SA, Nisenbaum ES, Salt TE. Group II Metabotropic Glutamate Receptor (mGlu2 and mGlu3) Roles in Thalamic Processing. British Journal of Pharmacology. PMID 34355803 DOI: 10.1111/bph.15640 |
0.293 |
|
| 2016 |
Kato AS, Burris KD, Gardinier KM, Gernert DL, Porter WJ, Reel J, Ding C, Tu Y, Schober DA, Lee MR, Heinz BA, Fitch TE, Gleason SD, Catlow JT, Yu H, ... ... Nisenbaum ES, et al. Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism. Nature Medicine. PMID 27820603 DOI: 10.1038/Nm.4221 |
0.287 |
|
| 1996 |
Nisenbaum ES, Wilson CJ, Foehring RC, Surmeier DJ. Isolation and characterization of a persistent potassium current in neostriatal neurons. Journal of Neurophysiology. 76: 1180-94. PMID 8871229 DOI: 10.1152/Jn.1996.76.2.1180 |
0.284 |
|
| 2014 |
Tan Z, Piekarz A, Priest B, Knopp K, Krajewski J, McDermott J, Nisenbaum E, Cummins T. (344) Tetrodotoxin-resistant sodium channels in sensory neurons generate slow resurgent currents that are enhanced by inflammatory mediators The Journal of Pain. 15. DOI: 10.1016/J.Jpain.2014.01.254 |
0.279 |
|
| 2012 |
Kato AS, Knierman MD, Siuda ER, Isaac JT, Nisenbaum ES, Bredt DS. Glutamate receptor δ2 associates with metabotropic glutamate receptor 1 (mGluR1), protein kinase Cγ, and canonical transient receptor potential 3 and regulates mGluR1-mediated synaptic transmission in cerebellar Purkinje neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 15296-308. PMID 23115168 DOI: 10.1523/Jneurosci.0705-12.2012 |
0.278 |
|
| 2007 |
Siuda ER, Quirk JC, Nisenbaum ES. Methods for evaluation of positive allosteric modulators of glutamate AMPA receptors. Methods in Molecular Biology (Clifton, N.J.). 403: 37-57. PMID 18827986 DOI: 10.1007/978-1-59745-529-9_3 |
0.268 |
|
| 2017 |
Felder CC, Schober DA, Tu Y, Quets AT, Xiao H, Watt M, Siuda ER, Nisenbaum ES, Xiang C, Heinz B, Prieto L, Mc Kinzie DL, Monn JA. Translational pharmacology of the mGluR2-preferring agonist LY2812223 in animal and human brain. The Journal of Pharmacology and Experimental Therapeutics. PMID 28138041 DOI: 10.1124/Jpet.116.237859 |
0.257 |
|
| 2017 |
Fouillet A, Watson JF, Piekarz AD, Huang X, Li B, Priest B, Nisenbaum E, Sher E, Ursu D. [EXPRESS] Characterisation of Nav1.7 functional expression in rat dorsal root ganglia neurons by using an electrical field stimulation assay. Molecular Pain. 1744806917745179. PMID 29166836 DOI: 10.1177/1744806917745179 |
0.256 |
|
| 2004 |
Quirk JC, Siuda ER, Nisenbaum ES. Molecular determinants responsible for differences in desensitization kinetics of AMPA receptor splice variants. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 11416-20. PMID 15601947 DOI: 10.1523/Jneurosci.2464-04.2004 |
0.25 |
|
| 2010 |
Schuelert N, Zhang C, Mogg AJ, Broad LM, Hepburn DL, Nisenbaum ES, Johnson MP, McDougall JJ. Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 18: 1536-43. PMID 20863899 DOI: 10.1016/j.joca.2010.09.005 |
0.243 |
|
| 2003 |
Quirk JC, Nisenbaum ES. Multiple molecular determinants for allosteric modulation of alternatively spliced AMPA receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 10953-62. PMID 14645491 |
0.242 |
|
| 2003 |
Zhai Y, George CA, Zhai J, Nisenbaum ES, Johnson MP, Nisenbaum LK. Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 45-52. PMID 12496939 DOI: 10.1038/sj.npp.1300013 |
0.227 |
|
| 2001 |
Harvey SC, Köster A, Yu H, Skolnick P, Baumbarger P, Nisenbaum ES. AMPA receptor function is altered in GLUR2-deficient mice. Journal of Molecular Neuroscience : Mn. 17: 35-43. PMID 11665861 DOI: 10.1385/Jmn:17:1:35 |
0.22 |
|
| 2017 |
Johnson MP, Muhlhauser MA, Nisenbaum ES, Simmons RM, Forster BM, Knopp KL, Yang L, Morrow D, Li DL, Kennedy JD, Swanson S, Monn JA. Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 (mGlu2/3 ) receptor agonist LY2934747, in rodent pain models. British Journal of Pharmacology. PMID 28177520 DOI: 10.1111/bph.13740 |
0.211 |
|
| 2013 |
Upadhyaya HP, Desaiah D, Schuh KJ, Bymaster FP, Kallman MJ, Clarke DO, Durell TM, Trzepacz PT, Calligaro DO, Nisenbaum ES, Emmerson PJ, Schuh LM, Bickel WK, Allen AJ. A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder. Psychopharmacology. 226: 189-200. PMID 23397050 DOI: 10.1007/s00213-013-2986-z |
0.211 |
|
| 2002 |
Quirk JC, Linden AM, Strakhova M, Yu H, Skolnick P, Nisenbaum ES. A single residue contributes sensitivity to allosteric modulation of AMPA receptors by LY395153. European Journal of Pharmacology. 454: 125-9. PMID 12421639 DOI: 10.1016/S0014-2999(02)02491-3 |
0.203 |
|
| 2017 |
Lee MR, Gardinier KM, Gernert DL, Schober DA, Wright RA, Wang H, Qian Y, Witkin JM, Nisenbaum ES, Kato AS. Structural Determinants of the γ-8 TARP Dependent AMPA Receptor Antagonist. Acs Chemical Neuroscience. PMID 28825787 DOI: 10.1021/Acschemneuro.7B00186 |
0.202 |
|
| 2010 |
Nisenbaum ES, Witkin JM. Positive allosteric modulation of AMPA receptors: A Novel potential antidepressant Therapy Milestones in Drug Therapy. 39-56. DOI: 10.1007/978-3-0346-0241-9_3 |
0.196 |
|
| 2013 |
Zanotti-Fregonara P, Barth VN, Liow JS, Zoghbi SS, Clark DT, Rhoads E, Siuda E, Heinz BA, Nisenbaum E, Dressman B, Joshi E, Luffer-Atlas D, Fisher MJ, Masters JJ, Goebl N, et al. Evaluation in vitro and in animals of a new 11C-labeled PET radioligand for metabotropic glutamate receptors 1 in brain. European Journal of Nuclear Medicine and Molecular Imaging. 40: 245-53. PMID 23135321 DOI: 10.1007/S00259-012-2269-7 |
0.196 |
|
| 2006 |
Zarrinmayeh H, Tromiczak E, Zimmerman DM, Rankl N, Ho KH, Dominguez E, Castaño A, Escribano A, Fernandez C, Jimenez A, Hornback WJ, Nisenbaum ES. A novel class of positive allosteric modulators of AMPA receptors: design, synthesis, and structure-activity relationships of 3-biphenyl-4-yl-4-cyano-5-ethyl-1-methyl-1H-pyrrole-2-carboxylic acid, LY2059346. Bioorganic & Medicinal Chemistry Letters. 16: 5203-6. PMID 16872827 DOI: 10.1016/j.bmcl.2006.07.012 |
0.186 |
|
| 2011 |
Yan LZ, Johnson KW, Rothstein E, Flora D, Edwards P, Li B, Li J, Lynch R, Vaughn R, Clemens-Smith A, McCarty D, Chow C, McKnight KL, Lu J, Nisenbaum ES, et al. Discovery of potent, cyclic calcitonin gene-related peptide receptor antagonists. Journal of Peptide Science : An Official Publication of the European Peptide Society. 17: 383-6. PMID 21412957 DOI: 10.1002/psc.1358 |
0.184 |
|
| 2021 |
Yu L, Tsuji K, Ujihara I, Liu Q, Pavelkova N, Tsujimura T, Inoue M, Meeker S, Nisenbaum E, McDermott JS, Krajewski J, Undem BJ, Kollarik M, Canning BJ. Antitussive effects of Na 1.7 blockade in guinea pigs. European Journal of Pharmacology. 174192. PMID 34010618 DOI: 10.1016/j.ejphar.2021.174192 |
0.182 |
|
| 2012 |
Fisher MJ, Backer RT, Barth VN, Garbison KE, Gruber JM, Heinz BA, Iyengar S, Hollinshead SP, Kingston A, Kuklish SL, Li L, Nisenbaum ES, Peters SC, Phebus L, Simmons RM, et al. 3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity. Bioorganic & Medicinal Chemistry Letters. 22: 2514-7. PMID 22386665 DOI: 10.1016/j.bmcl.2012.02.003 |
0.182 |
|
| 2006 |
Fernandez MC, Castaño A, Dominguez E, Escribano A, Jiang D, Jimenez A, Hong E, Hornback WJ, Nisenbaum ES, Rankl N, Tromiczak E, Vaught G, Zarrinmayeh H, Zimmerman DM. A novel class of AMPA receptor allosteric modulators. Part 1: design, synthesis, and SAR of 3-aryl-4-cyano-5-substituted-heteroaryl-2-carboxylic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 16: 5057-61. PMID 16879964 DOI: 10.1016/j.bmcl.2006.07.035 |
0.178 |
|
| 2014 |
Tan ZY, Priest BT, Krajewski JL, Knopp KL, Nisenbaum ES, Cummins TR. Protein kinase C enhances human sodium channel hNav1.7 resurgent currents via a serine residue in the domain III-IV linker. Febs Letters. 588: 3964-9. PMID 25240195 DOI: 10.1016/J.Febslet.2014.09.011 |
0.171 |
|
| 2001 |
Salamone JD, Correa M, Carlson BB, Wisniecki A, Mayorga AJ, Nisenbaum E, Nisenbaum L, Felder C. Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents implications for cholinergic involvement in parkinsonism. Life Sciences. 68: 2579-84. PMID 11392629 DOI: 10.1016/S0024-3205(01)01055-4 |
0.164 |
|
| 2014 |
Kierans AS, Kirov II, Gonen O, Haemer G, Nisenbaum E, Babb JS, Grossman RI, Lui YW. Myoinositol and glutamate complex neurometabolite abnormality after mild traumatic brain injury. Neurology. 82: 521-8. PMID 24401686 DOI: 10.1212/Wnl.0000000000000105 |
0.158 |
|
| 2011 |
Timm DE, Benveniste M, Weeks AM, Nisenbaum ES, Partin KM. Structural and functional analysis of two new positive allosteric modulators of GluA2 desensitization and deactivation. Molecular Pharmacology. 80: 267-80. PMID 21543522 DOI: 10.1124/Mol.110.070243 |
0.153 |
|
| 2017 |
Kocmalova M, Kollarik M, Canning BJ, Ru F, Herbstromer RA, Meeker S, Fonquerna S, Aparici M, Miralpeix M, Chi X, Li B, Wilenkin B, McDermott J, Nisenbaum E, Krajewski J, et al. Control of Neurotransmission by NaV1.7 in Human, Guinea pig, and Mouse airway Parasympathetic Nerves. The Journal of Pharmacology and Experimental Therapeutics. PMID 28138042 DOI: 10.1124/Jpet.116.238469 |
0.153 |
|
| 2013 |
Zanotti-Fregonara P, Barth VN, Zoghbi SS, Liow JS, Nisenbaum E, Siuda E, Gladding RL, Rallis-Frutos D, Morse C, Tauscher J, Pike VW, Innis RB. 11C-LY2428703, a positron emission tomographic radioligand for the metabotropic glutamate receptor 1, is unsuitable for imaging in monkey and human brains. Ejnmmi Research. 3: 47. PMID 23758896 DOI: 10.1186/2191-219X-3-47 |
0.132 |
|
| 2006 |
Bleakman D, Alt A, Nisenbaum ES. Glutamate receptors and pain. Seminars in Cell & Developmental Biology. 17: 592-604. PMID 17110139 DOI: 10.1016/j.semcdb.2006.10.008 |
0.129 |
|
| 2019 |
Knopp K, Kato A, Wall T, Mcdermott JS, Nisenbaum ES, Adams B, Johnson M. Sat0051 Baricitinib Improves Joint Mobility After Injury In A Rodent Forced-Ambulation Model Annals of the Rheumatic Diseases. 78: 1089-1089. DOI: 10.1136/Annrheumdis-2019-Eular.1751 |
0.084 |
|
| 2020 |
Mittal R, Bencie N, Liu G, Eshraghi N, Nisenbaum E, Blanton SH, Yan D, Mittal J, Dinh CT, Young JI, Gong F, Liu XZ. Recent Advancements in Understanding the Role of Epigenetics in the Auditory System. Gene. 144996. PMID 32738421 DOI: 10.1016/j.gene.2020.144996 |
0.082 |
|
| 2021 |
Nourbakhsh A, Colbert BM, Nisenbaum E, El-Amraoui A, Dykxhoorn DM, Koehler KR, Chen ZY, Liu XZ. Stem Cells and Gene Therapy in Progressive Hearing Loss: the State of the Art. Journal of the Association For Research in Otolaryngology : Jaro. PMID 33507440 DOI: 10.1007/s10162-020-00781-0 |
0.072 |
|
| 2020 |
Dinh CT, Nisenbaum E, Chyou D, Misztal C, Yan D, Mittal R, Young J, Tekin M, Telischi F, Fernandez-Valle C, Liu XZ. Genomics, Epigenetics, and Hearing Loss in Neurofibromatosis Type 2. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. PMID 32150022 DOI: 10.1097/Mao.0000000000002613 |
0.067 |
|
| 2020 |
Jimenez JE, Nourbakhsh A, Colbert B, Mittal R, Yan D, Green CL, Nisenbaum E, Liu G, Bencie N, Rudman J, Blanton SH, Zhong Liu X. Diagnostic and Therapeutic Applications of Genomic Medicine in Progressive, Late-Onset, Nonsyndromic Sensorineural Hearing Loss. Gene. 144677. PMID 32304785 DOI: 10.1016/j.gene.2020.144677 |
0.054 |
|
| 2018 |
Sampson WWL, Khan SA, Nisenbaum EJ, Kralik JD. Abstraction promotes creative problem-solving in rhesus monkeys. Cognition. 176: 53-64. PMID 29547710 DOI: 10.1016/j.cognition.2018.02.021 |
0.053 |
|
| 2020 |
Qiu C, Cui C, Hautefort C, Haehner A, Zhao J, Yao Q, Zeng H, Nisenbaum EJ, Liu L, Zhao Y, Zhang D, Levine CG, Cejas I, Dai Q, Zeng M, et al. Olfactory and Gustatory Dysfunction as An Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study. Medrxiv : the Preprint Server For Health Sciences. PMID 32511546 DOI: 10.1101/2020.05.13.20100198 |
0.05 |
|
| 2014 |
Nisenbaum EJ, Novikov DS, Lui YW. The presence and role of iron in mild traumatic brain injury: an imaging perspective. Journal of Neurotrauma. 31: 301-7. PMID 24295521 DOI: 10.1089/neu.2013.3102 |
0.048 |
|
| 2021 |
Nisenbaum E, Misztal C, Szczupak M, Thielhelm T, Peña S, Mei C, Goncalves S, Bracho O, Ma R, Ivan ME, Morcos J, Telischi F, Liu XZ, Fernandez-Valle C, Dinh CT. Tumor-Associated Macrophages in Vestibular Schwannoma and Relationship to Hearing. Oto Open. 5: 2473974X211059111. PMID 34870062 DOI: 10.1177/2473974X211059111 |
0.044 |
|
| 2021 |
Nisenbaum E, Thielhelm TP, Nourbakhsh A, Yan D, Blanton SH, Shu Y, Koehler KR, El-Amraoui A, Chen Z, Lam BL, Liu X. Review of Genotype-Phenotype Correlations in Usher Syndrome. Ear and Hearing. PMID 34039936 DOI: 10.1097/AUD.0000000000001066 |
0.041 |
|
| 2023 |
Telischi J, Nisenbaum E, Nicolli E. Carotid endarterectomy for the management of carotid stenosis occurring concurrently with head and neck cancer. Current Opinion in Otolaryngology & Head and Neck Surgery. 31: 452-456. PMID 37916904 DOI: 10.1097/MOO.0000000000000928 |
0.039 |
|
| 2020 |
Qiu C, Cui C, Hautefort C, Haehner A, Zhao J, Yao Q, Zeng H, Nisenbaum EJ, Liu L, Zhao Y, Zhang D, Levine CG, Cejas I, Dai Q, Zeng M, et al. Olfactory and Gustatory Dysfunction as an Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 194599820934376. PMID 32539586 DOI: 10.1177/0194599820934376 |
0.038 |
|
| 2021 |
Mei C, Dong H, Nisenbaum E, Thielhelm T, Nourbakhsh A, Yan D, Smeal M, Lundberg Y, Hoffer ME, Angeli S, Telischi F, Nie G, Blanton SH, Liu X. Genetics and the Individualized Therapy of Vestibular Disorders. Frontiers in Neurology. 12: 633207. PMID 33613440 DOI: 10.3389/fneur.2021.633207 |
0.036 |
|
| 2020 |
Zhao Y, Cui C, Zhang K, Liu J, Xu J, Nisenbaum E, Huang Y, Qin G, Chen B, Hoffer M, Blanton SH, Telischi F, Hare JM, Daunert S, Shukla B, et al. COVID19: A Systematic Approach to Early Identification and Healthcare Worker Protection. Frontiers in Public Health. 8: 205. PMID 32574296 DOI: 10.3389/Fpubh.2020.00205 |
0.033 |
|
| 2020 |
Cui C, Yao Q, Zhang D, Zhao Y, Zhang K, Nisenbaum E, Cao P, Zhao K, Huang X, Leng D, Liu C, Li N, Luo Y, Chen B, Casiano R, et al. Approaching Otolaryngology Patients During the COVID-19 Pandemic. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 194599820926144. PMID 32396445 DOI: 10.1177/0194599820926144 |
0.03 |
|
| 2023 |
Nisenbaum E, Yan D, Shearer AE, de Joya E, Thielhelm T, Russell N, Staecker H, Chen Z, Holt JR, Liu X. Genotype-Phenotype Correlations in TMPRSS3 (DFNB10/DFNB8) with Emphasis on Natural History. Audiology & Neuro-Otology. 1-13. PMID 37331337 DOI: 10.1159/000528766 |
0.029 |
|
| 2023 |
Nisenbaum E, Wiefels M, Telischi J, Marasigan M, Kanumuri V, Pena S, Thielhelm T, Bracho O, Bhatia R, Scaglione T, Telischi F, Fernandez-Valle C, Liu XZ, Luther E, Morcos J, et al. Cytokine Profiling of Cyst Fluid and Tumor-Associated Macrophages in Cystic Vestibular Schwannoma. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. PMID 37853737 DOI: 10.1097/MAO.0000000000004032 |
0.025 |
|
| 2021 |
Nisenbaum E, Prentiss S, Yan D, Nourbakhsh A, Smeal M, Holcomb M, Cejas I, Telischi F, Liu XZ. Screening Strategies for Deafness Genes and Functional Outcomes in Cochlear Implant Patients. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 42: 180-187. PMID 33885265 DOI: 10.1097/MAO.0000000000002969 |
0.022 |
|
| 2011 |
Knopp KL, Nisenbaum ES, Arneric SP. Evolving cancer pain treatments: rational approaches to improve the quality of life for cancer patients. Current Pharmaceutical Biotechnology. 12: 1627-43. PMID 21466450 |
0.021 |
|
| 2020 |
Cheng X, Liu J, Li N, Nisenbaum E, Sun Q, Chen B, Casiano R, Weed D, Telischi F, Denneny JC, Liu X, Shu Y. Otolaryngology Providers Must Be Alert for Patients with Mild and Asymptomatic COVID-19. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 194599820920649. PMID 32286913 DOI: 10.1177/0194599820920649 |
0.02 |
|
| 2007 |
O'Neill MJ, Messenger MJ, Lakics V, Murray TK, Karran EH, Szekeres PG, Nisenbaum ES, Merchant KM. Neuroreplacement, growth factor, and small molecule neurotrophic approaches for treating Parkinson's disease. International Review of Neurobiology. 77: 179-217. PMID 17178475 DOI: 10.1016/S0074-7742(06)77006-4 |
0.019 |
|
| 2020 |
Nisenbaum EJ, Roland JT, Waltzman S, Friedmann DR. Risk Factors and Management of Postoperative Infection Following Cochlear Implantation. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 41: e823-e828. PMID 32658104 DOI: 10.1097/MAO.0000000000002685 |
0.019 |
|
| 2014 |
Benschop RJ, Collins EC, Darling RJ, Allan BW, Leung D, Conner EM, Nelson J, Gaynor B, Xu J, Wang XF, Lynch RA, Li B, McCarty D, Nisenbaum ES, Oskins JL, et al. Corrigendum to "Development of a novel antibody to Calcitonin Gene-Related Peptide for the treatment of osteoarthritis-related pain" [Osteoarthritis Cartilage 22 (2014) 578-585] (DOI:10.1016/j.joca.2014.01.009) Osteoarthritis and Cartilage. DOI: 10.1016/j.joca.2014.08.003 |
0.014 |
|
| 2023 |
Peifer S, Carey R, Nisenbaum E, Leibowitz J, Nicolli E. Cautionary case for radial forearm free flap use in trisomy 21. Head & Neck. PMID 37589165 DOI: 10.1002/hed.27484 |
0.01 |
|
| 1995 |
Waldman H, Nisenbaum E. Upper Bounds and Hamming Spheres Under the DC Constraint Ieee Transactions On Information Theory. 41: 1138-1145. DOI: 10.1109/18.391257 |
0.01 |
|
| 1994 |
Waldman H, Nisenbaum E. Upper bounds and Hamming spheres under the DC-constraint Ieee International Symposium On Information Theory - Proceedings. 207. DOI: 10.1109/ISIT.1994.394761 |
0.01 |
|
| 1957 |
MAISTERRENA J, ROMERO F, NISENBAUM E, MARTINEZ S. [Medical treatment of hyperthyroidism]. Revista De Investigaciã³N ClãNica; Organo Del Hospital De Enfermedades De La Nutriciã³N. 9: 199-210. PMID 13485610 |
0.01 |
|
| Hide low-probability matches. |